• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Journal of the Neurological Sciences

    Journal of the Neurological Sciences

    JournalISSN 0022-510XeISSN 1878-5883中科院 医学 3区

    年发文量

    研究主题

    论文(174463)

    排序
    1Describing the Pre-Moyamoya Stage: Lesion Distribution, Disease Progression, and the Impact of RNF213
    Tomoki Sasagasako,Yohei Mineharu,Takeshi Funaki,Hideo Chihara, Aravind Ganesh,Sachi Okuchi,Silsu Park,Kota Nakajima,Masakazu Okawa,Takayuki Kikuchi,Yasutaka Fushimi,Yoshiki Arakawa
    2027
    引用
    AI阅读
    加入学术空间
    2Time for Functional Complement Biomarkers in Generalized Myasthenia Gravis
    Giuseppe Di Martino,Nicasio Rini,Vincenzo Di Stefano
    2027
    引用
    AI阅读
    加入学术空间
    3Psychosocial Impacts of Post-Acute Sequelae of COVID-19: Insights from a Longitudinal Cohort
    Gerome Vallejos,Carla Y. Kim,Luisa F. Alviz, Alexandra Diaz-Ariza, Kathryn B. Holroyd, Blen Mamo,Kiran T. Thakur
    2027
    引用
    AI阅读
    加入学术空间
    4ALSFRS-R Item Comparability and Respiratory Validation in Data-Driven ALS Progression Modeling
    Beixing Yang
    2026
    引用
    AI阅读
    加入学术空间
    5Advances in Research and Clinical Decision Strategies for Anticoagulation Timing in Acute Ischemic Stroke Patients with Atrial Fibrillation
    Qi Wang, Jing Huang, Jingwen Xia, Linjie Xie, Chaochen Yin,Ruijuan Gang, Yujie Tang, Pengyuan Wang, Yuetong Luo, Xiong Yu, Qiushuo Liu, Chenlin Hu,

    Atrial fibrillation (AF) is a major risk factor for acute ischemic stroke (AIS), and oral anticoagulation is the cornerstone of secondary prevention. The optimal timing of anticoagulation initiation remains controversial because of the need to balance the risks of early ischemic recurrence and hemorrhagic transformation. Recent randomized controlled trials and meta-analyses indicate that early initiation of direct oral anticoagulants (DOACs) is generally safe in appropriately selected patients and may reduce recurrent ischemic events without increasing the risk of symptomatic intracranial hemorrhage. However, evidence remains limited in patients with severe stroke, hemorrhagic transformation, large infarcts, or recent reperfusion therapy, in whom the timing of anticoagulation should be individualized according to clinical and neuroimaging characteristics. The 2026 AHA/ASA guideline considers early oral anticoagulation reasonable in carefully selected patients with AIS and AF, particularly those with milder stroke severity, without specifying a uniform initiation window. Clinical decision-making should integrate stroke severity, neuroimaging findings, and individual thromboembolic and bleeding risks. Overall, current evidence supports a shift from fixed delay rules toward individualized anticoagulation strategies.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 174463 篇论文

    高被引作者

    作者引用发文
    Mark Daly5418578
    Pak Chung Sham4629138
    Shaun Purcell4557114
    Paul I W de Bakker4462519
    Pamela Sklar4370819
    Manuel A. R. Ferreira426658
    David P Bender414631
    Julian B. Maller414631
    Werner Poewe38775565
    Anthony E. Lang27396369

    高产作者

    作者引用发文
    Ludwig Kappos23018835
    Comi Giancarlo21921708
    Filippi Massimo19834622
    Werner Poewe38775565
    Gavin Giovannoni8178502
    Frederik Barkhof21770498
    Maria Assunta Rocca5882451
    Kaliash Bhatia23377428
    Helmut Butzkueven5023424
    Xavier Montalban5691422

    相关期刊

    European neurology
    Journal of Neurology, Neurosurgery and Psychiatry
    Multiple Sclerosis Journal
    European Journal Of Neurology
    BMC neurology
    JAMA neurology
    Neurology
    Neurological Sciences
    The Lancet Neurology
    Journal of Neurology